150 related articles for article (PubMed ID: 2203292)
1. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study.
Loehrer PJ; Perez CA; Roth LM; Greco A; Livingston RB; Einhorn LH
Ann Intern Med; 1990 Oct; 113(7):520-4. PubMed ID: 2203292
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Loehrer PJ; Kim K; Aisner SC; Livingston R; Einhorn LH; Johnson D; Blum R
J Clin Oncol; 1994 Jun; 12(6):1164-8. PubMed ID: 8201378
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of invasive thymoma.
Fornasiero A; Daniele O; Ghiotto C; Sartori F; Rea F; Piazza M; Fiore-Donati L; Morandi P; Aversa SM; Paccagnella A
J Clin Oncol; 1990 Aug; 8(8):1419-23. PubMed ID: 2380761
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and operation for invasive thymoma.
Rea F; Sartori F; Loy M; Calabrò F; Fornasiero A; Daniele O; Altavilla G
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):543-9. PubMed ID: 8361199
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for invasive thymoma. A 13-year experience.
Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; Calabró F; Rea F; Fiorentino MV
Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of invasive or metastatic thymoma: report of 11 cases.
Fornasiero A; Daniele O; Sperandio P; Morandi P; Fosser VP; Cartei G; Fiorentino MV
Cancer Treat Rep; 1984 Oct; 68(10):1205-10. PubMed ID: 6543151
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of malignant thymoma. Case report and review of the literature.
Hu E; Levine J
Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
[TBL] [Abstract][Full Text] [Related]
12. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
13. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Giaccone G; Ardizzoni A; Kirkpatrick A; Clerico M; Sahmoud T; van Zandwijk N
J Clin Oncol; 1996 Mar; 14(3):814-20. PubMed ID: 8622029
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone.
Yokoi K; Matsuguma H; Nakahara R; Kondo T; Kamiyama Y; Mori K; Miyazawa N
J Thorac Oncol; 2007 Jan; 2(1):73-8. PubMed ID: 17410014
[TBL] [Abstract][Full Text] [Related]
16. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide.
Lara PN; Bonomi PD; Faber LP
Chest; 1996 Oct; 110(4):1115-7. PubMed ID: 8874280
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of thymoma].
Monden Y; Uyama T; Kimura S; Takahashi K
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2019-24. PubMed ID: 2221924
[TBL] [Abstract][Full Text] [Related]
18. Thymoma. A retrospective study of 87 cases.
Park HS; Shin DM; Lee JS; Komaki R; Pollack A; Putnam JB; Cox JD; Hong WK
Cancer; 1994 May; 73(10):2491-8. PubMed ID: 8174044
[TBL] [Abstract][Full Text] [Related]
19. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
Loehrer PJ; Lauer R; Roth BJ; Williams SD; Kalasinski LA; Einhorn LH
Ann Intern Med; 1988 Oct; 109(7):540-6. PubMed ID: 2844110
[TBL] [Abstract][Full Text] [Related]
20. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
Grassin F; Paleiron N; André M; Caliandro R; Bretel JJ; Terrier P; Margery J; Le Chevalier T; Ruffié P
J Thorac Oncol; 2010 Jun; 5(6):893-7. PubMed ID: 20521356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
